- 全部删除
您的购物车当前为空
HG-7-86-01是有效和选择性的II型酪氨酸激酶抑制剂,对突变体T315I- Bcr-Abl具有抗增殖活性,用于治疗慢性髓性白血病(CML)。


为众多的药物研发团队赋能,
让新药发现更简单!
HG-7-86-01是有效和选择性的II型酪氨酸激酶抑制剂,对突变体T315I- Bcr-Abl具有抗增殖活性,用于治疗慢性髓性白血病(CML)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 687 | In stock | |
| 5 mg | ¥ 1,680 | In stock | |
| 10 mg | ¥ 2,690 | In stock | |
| 25 mg | ¥ 4,390 | In stock | |
| 50 mg | ¥ 6,220 | In stock | |
| 100 mg | ¥ 8,380 | In stock | |
| 200 mg | ¥ 11,300 | In stock |
HG-7-86-01 相关产品
| 产品描述 | HG-7-86-01 is a potent and selective type II tyrosine kinase inhibitor with antiproliferative activity against mutant T315I- Bcr-Abl for the treatment of chronic myeloid leukemia (CML). |
| 体外活性 | HG-7-86-01 在多种携带突变型 FLT3 的细胞系中表现出有效的抗增殖活性: |
| 分子量 | 562.57 |
| 分子式 | C28H21F3N6O2S |
| CAS No. | 1258391-14-8 |
| Smiles | O=C(NC=1C=C(C=C(C1)C(F)(F)F)N2C=NC(=C2)C)C3=CC=CC(=C3)C4=NC=5SC(=NC5C=C4)NC(=O)C6CC6 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
| 溶解度信息 | DMSO: 2 mg/mL (3.56 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
DMSO
| |||||||||||
评论内容